Abstract: A semiconductor memory device performs: an erase voltage supply operation that applies an erase voltage to a first wiring; a first erase verify operation that applies a read pass voltage to a first conductive layer, and applies an erase verify voltage to a second conductive layer after performing the erase voltage supply operation; and a second erase verify operation that applies the erase verify voltage to the first conductive layer, and applies the read pass voltage to the second conductive layer after performing the first erase verify operation. The erase voltage increases by a first offset voltage in each erase loop from a first erase loop to an a-th erase loop, and the erase voltage increases by a second offset voltage in each erase loop from an a+1-th erase loop to a b-th erase loop. The second offset voltage is larger than the first offset voltage.

Abstract: A method of inspecting a semiconductor device in which a plurality of conductive members is stacked includes drilling through the conductive layers using a drill and, while drilling, monitoring a probe device that is electrically connected to one of the conductive layers. When an electrical connection is established between the drill and probe device, the drilling is halted and said one of the conductive layers is inspected.

Abstract: The invention is to develop an agent having at least one of anticalcipenic, antiedemic and diuretic activities for humans or animals and to inhibit the postpartum drop of the calcium concentration in blood, thereby maintaining the health of the mother body and smoothing nursing and lactation. In the invention, difructose anhydride (DFA) being a disaccharide made of two molecules of fructose coupled together is administered. In particular, for inhibiting the postpartum drop of the calcium concentration in blood, DFA III and/or DFA IV is administered before childbirth delivery (in a cow, before an expected date of calving). The joint use of a calcium agent or vitamin D is possible as required.

Abstract: The invention is to develop an agent having at least one of anricalclpenic, antiedemic and diuretic activities for humans or animals and to inhibit the postpartum drop of the calcium concentration in blood, thereby maintaining the health of the mother body and smoothing nursing and lactation. In the invention, difructose anhydride (DTA) being a disaccharide made of two molecules of fructose coupled together is administered. In particular, for inhibiting the postpartum drop of the calcium concentration in blood, DFA III and/or DFA IV is administered before childbirth delivery (in a cow, before an expected date of calving). The joint use of a calcium agent or vitamin D is possible as required.